![Michael Jasulavic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Jasulavic
Gründer bei
Regel Therapeutics Inc.
Profil
Michael Jasulavic is the founder of Regel Therapeutics Inc. since 2020, holding the title of Director.
Current jobs include Director at ConnectRN, Inc., Director at SCRIPT Biosciences, Inc., Advisor at HBM Partners AG since 2012, and Partner at Phifund Managers, LLC.
Former jobs include Director at Tevard Biosciences, Inc., Equity Trader at Knight Capital Group, Inc. from 1998 to 2007, Biotechnology Analyst at Sivik Global Healthcare LLC (Old), Principal at Traxis Partners LP from 2011 to 2012, and Analyst & Trader at CoreCommodity Management LLC from 2007 to 2008.
Education includes an undergraduate degree from Fairfield University conferred in 1996 and a graduate degree from Drexel University College of Medicine conferred in 1998.
Aktive Positionen von Michael Jasulavic
| Unternehmen | Position | Beginn |
|---|---|---|
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Private-Equity-Analyst | 01.05.2012 |
ConnectRN, Inc.
 ConnectRN, Inc. Internet Software/ServicesTechnology Services Operates as an online platform that connects hospitals with available nurses | Direktor/Vorstandsmitglied | - |
Regel Therapeutics Inc.
 Regel Therapeutics Inc. BiotechnologyHealth Technology Develops proprietary technology platform related to gene therapy | Gründer | 01.01.2020 |
Phifund Managers, LLC
 Phifund Managers, LLC Investment ManagersFinance Phifund Managers invests in private companies located in the United States. The firm focuses on healthcare. It participates in early stage transactions. | Private Equity Investor | - |
Script Biosciences, Inc.
 Script Biosciences, Inc. Packaged SoftwareTechnology Services Develops genome editing platform | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Jasulavic
| Unternehmen | Position | Ende |
|---|---|---|
CoreCommodity Management LLC
 CoreCommodity Management LLC Investment ManagersFinance CoreCommodity offers various investment programs or strategies which seek to deliver superior risk-adjusted returns relative to selected benchmark indexes. The firm’s absolute return program seeks to provide positive returns to investors irrespective of the directional performance of the asset class. They additionally offer natural resource equity strategies that seek to provide global, diversified commodity exposure and capital appreciation. | Corporate Officer/Principal | 31.10.2008 |
Knight Capital Group, Inc.
 Knight Capital Group, Inc. Investment Banks/BrokersFinance Provides securities services to broker dealers and institutional customers | Corporate Officer/Principal | 01.02.2007 |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases | Direktor/Vorstandsmitglied | - |
Traxis Partners LP
 Traxis Partners LP Investment ManagersFinance Traxis Partners specializes in global, multi-asset class investment strategies. | Corporate Officer/Principal | - |
| ░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Michael Jasulavic
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Knight Capital Group, Inc.
Knight Capital Group, Inc. Investment Banks/BrokersFinance Provides securities services to broker dealers and institutional customers | Finance |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
Sivik Global Healthcare LLC (Old)
 Sivik Global Healthcare LLC (Old) Investment ManagersFinance Sivik invests almost exclusively in US growth stocks in the healthcare technology and services sector without regard to capitalization size. They use a combination top-down, bottom-up approach to find companies with new drugs or technologies and sector dominance or competitive advantages. SIVIK maintains a high turnover | Finance |
Traxis Partners LP
Traxis Partners LP Investment ManagersFinance Traxis Partners specializes in global, multi-asset class investment strategies. | Finance |
CoreCommodity Management LLC
CoreCommodity Management LLC Investment ManagersFinance CoreCommodity offers various investment programs or strategies which seek to deliver superior risk-adjusted returns relative to selected benchmark indexes. The firm’s absolute return program seeks to provide positive returns to investors irrespective of the directional performance of the asset class. They additionally offer natural resource equity strategies that seek to provide global, diversified commodity exposure and capital appreciation. | Finance |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ConnectRN, Inc.
ConnectRN, Inc. Internet Software/ServicesTechnology Services Operates as an online platform that connects hospitals with available nurses | Technology Services |
Tevard Biosciences, Inc.
Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases | Commercial Services |
Regel Therapeutics Inc.
Regel Therapeutics Inc. BiotechnologyHealth Technology Develops proprietary technology platform related to gene therapy | Health Technology |
Script Biosciences, Inc.
Script Biosciences, Inc. Packaged SoftwareTechnology Services Develops genome editing platform | Technology Services |
Phifund Managers, LLC
Phifund Managers, LLC Investment ManagersFinance Phifund Managers invests in private companies located in the United States. The firm focuses on healthcare. It participates in early stage transactions. | Finance |
